Human Umbilical Cord Blood-Derived Monocytes Improve Cognitive Deficits and Reduce Amyloid-β Pathology in PSAPP Mice
Alzheimer's disease (AD) is the fourth major cause of mortality in the elderly in the US and the leading cause of dementia worldwide. While pharmacological targets have been discovered, there are no true disease-modifying therapies. We have recently discovered that multiple low-dose infusions o...
Main Authors: | Donna Darlington, Song Li, Huayan Hou, Ahsan Habib, Jun Tian, Yang Gao, Jared Ehrhart, Paul R Sanberg, Darrell Sawmiller, Brian Giunta, Takashi Mori, Jun Tan |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2015-11-01
|
Series: | Cell Transplantation |
Online Access: | https://doi.org/10.3727/096368915X688894 |
Similar Items
-
Human Umbilical Cord Blood Serum–derived α-Secretase
by: Ahsan Habib, et al.
Published: (2018-03-01) -
Biodistribution of Infused Human Umbilical Cord Blood Cells in Alzheimer's Disease-Like Murine Model
by: Jared Ehrhart Ph.D., et al.
Published: (2016-01-01) -
Human Cord Blood Serum-Derived APP α-Secretase Cleavage Activity is Mediated by C1 Complement
by: Ahsan Habib, et al.
Published: (2018-04-01) -
Implications of Human Umbilical Cord Blood Cells: An Immunotherapeutic Strategy for Alzheimer's Disease
by: Darlington, Donna
Published: (2014) -
A Hallmark Clinical Study of Cord Blood Therapy in Adults with Ischemic Stroke
by: Paul R. Sanberg, et al.
Published: (2019-09-01)